Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Dijk

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Critical Reviews in Oncology/Hematology|June 4, 2019
Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tractE Roos, E C Soer, S Klompmaker, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 13, 2017
Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysisA Creemers, S Krausz, M Strijker, et al.
Oncogenesis|November 17, 2018
ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapyV L Veenstra, H Damhofer, C Waasdorp, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Critical Reviews in Oncology/Hematology|June 4, 2019
Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tractE Roos, E C Soer, S Klompmaker, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 13, 2017
Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysisA Creemers, S Krausz, M Strijker, et al.
Oncogenesis|November 17, 2018
ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapyV L Veenstra, H Damhofer, C Waasdorp, et al.
Pageof 6